We are live on ! Find out more
CB

Christopher Bloomstran Semper Augustus Investments Group

AUM $885M
1-Year Est. Return 30.72%
 

Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.

This Fund
S&P 500
This Quarter Est. Return
-2.69%
1 Year Est. Return
+30.72%
3 Year Est. Return
+95.38%
5 Year Est. Return
+117.62%
10 Year Est. Return
+411.84%
AUM
$154M
AUM Growth
-$2.73M
Cap. Flow
+$1.85M
Cap. Flow %
1.2%
Top 10 Hldgs %
74.38%
Holding
32
New
2
Increased
4
Reduced
6
Closed
1

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$398K
2
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$34K
3
JNJ icon
Johnson & Johnson
JNJ
+$12.7K
4
EQNR icon
Equinor
EQNR
+$7.13K
5
NEM icon
Newmont
NEM
+$7.01K

Sector Composition

Rank Sector Weight
1 Financials 51.97%
2 Energy 15.77%
3 Materials 7.85%
4 Healthcare 7.62%
5 Technology 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KGC icon
26
Kinross Gold
KGC
$38.9B
$1.23M 0.8%
550,678
-700
-0.1% -$2.04K
CB
27
DELISTED
CHUBB CORPORATION
CB
$1.01M 0.66%
10,000
MDT icon
28
Medtronic
MDT
$119B
$390K 0.25%
5,000
FRTX
29
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$384K 0.25%
129
RDS.A
30
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$290K 0.19%
5,212
DST
31
DELISTED
DST Systems Inc.
DST
$271K 0.18%
+4,900
New +$252K
AMPE
32
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-33
Closed -$34K

Similar funds

Christopher Bloomstran's Q1 2015 Portfolio in Review

As of Q1 2015, Christopher Bloomstran held 32 positions worth $154M, down 1.7% from $157M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Christopher Bloomstran's Q1 2015 filing shows 2 new, 4 increased, 6 reduced and 1 closed positions. Its largest new stake was American Express: 24,143 shares worth $1.89M. The largest sale was Merck, an estimated $398K.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 51% a quarter earlier, followed by Energy and Materials.

  • Christopher Bloomstran's largest Q1 2015 buy was American Express: 24,143 shares worth $1.89M.
  • Christopher Bloomstran added most to Microsoft in Q1 2015, an estimated $23.5K increase.
  • Christopher Bloomstran's biggest Q1 2015 reduction was Merck, cutting an estimated $398K.
  • Christopher Bloomstran fully exited Ampio Pharmaceuticals Inc. in Q1 2015, selling an estimated $34K.
  • Christopher Bloomstran's ten largest holdings make up 74% of its $154M portfolio in Q1 2015.
  • Christopher Bloomstran opened 2 new positions and closed 1 in Q1 2015.
  • Christopher Bloomstran's portfolio value fell 1.7% quarter-over-quarter to $154M.

Based on Semper Augustus Investments Group's 13F filing for Q1 2015, filed 14 May 2015.